1. Home
  2. GKOS vs WPP Comparison

GKOS vs WPP Comparison

Compare GKOS & WPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • WPP
  • Stock Information
  • Founded
  • GKOS 1998
  • WPP 1985
  • Country
  • GKOS United States
  • WPP United Kingdom
  • Employees
  • GKOS N/A
  • WPP N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • WPP Advertising
  • Sector
  • GKOS Health Care
  • WPP Consumer Discretionary
  • Exchange
  • GKOS Nasdaq
  • WPP Nasdaq
  • Market Cap
  • GKOS 5.4B
  • WPP 5.9B
  • IPO Year
  • GKOS 2015
  • WPP N/A
  • Fundamental
  • Price
  • GKOS $82.38
  • WPP $26.24
  • Analyst Decision
  • GKOS Strong Buy
  • WPP Sell
  • Analyst Count
  • GKOS 12
  • WPP 1
  • Target Price
  • GKOS $128.58
  • WPP N/A
  • AVG Volume (30 Days)
  • GKOS 698.2K
  • WPP 362.6K
  • Earning Date
  • GKOS 11-03-2025
  • WPP 08-07-2025
  • Dividend Yield
  • GKOS N/A
  • WPP 9.92%
  • EPS Growth
  • GKOS N/A
  • WPP 86.47
  • EPS
  • GKOS N/A
  • WPP 0.47
  • Revenue
  • GKOS $432,953,000.00
  • WPP $19,423,208,660.00
  • Revenue This Year
  • GKOS $28.79
  • WPP N/A
  • Revenue Next Year
  • GKOS $25.65
  • WPP N/A
  • P/E Ratio
  • GKOS N/A
  • WPP $55.39
  • Revenue Growth
  • GKOS 26.70
  • WPP N/A
  • 52 Week Low
  • GKOS $77.10
  • WPP $24.28
  • 52 Week High
  • GKOS $163.71
  • WPP $57.37
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 35.40
  • WPP 41.66
  • Support Level
  • GKOS $80.52
  • WPP $26.70
  • Resistance Level
  • GKOS $95.32
  • WPP $27.23
  • Average True Range (ATR)
  • GKOS 2.82
  • WPP 0.45
  • MACD
  • GKOS -1.23
  • WPP 0.11
  • Stochastic Oscillator
  • GKOS 11.29
  • WPP 17.11

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About WPP WPP plc

Headquartered in the United Kingdom, WPP is the world's largest ad holding company based on annual revenue. Its services, which include traditional and digital advertising, public relations, and consulting, are provided worldwide, with over 70% of its revenue coming from more developed regions such as North America, the UK, and Western Europe. WPP is the largest media buying entity in the world.

Share on Social Networks: